P178 CORONARY PATIENTS REACHING LDL-CHOLESTEROL < 2.0 mmol/L HAVE THE LOWEST RISK OF CARDIOVASCULAR EVENTS DURING STATIN TREATMENT: THE IDEAL STUDY
ATHEROSCLEROSIS SUPPLEMENTS(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ATHEROSCLEROSIS SUPPLEMENTS(2010)